Five weeks into this series and we have moved from the plant outward. We examined what sucrose does inside the stem. We looked at how the brain responds to decades of heavy use. We watched scientists coax a naked cell back to life. We mapped the microscopic architecture of the flower itself. This week we turn to something that connects the plant to the person in a way most growers have never considered.

Your body has its own endocannabinoid system. It produces its own cannabinoid-like molecules. And a growing body of peer-reviewed evidence suggests that moderate-intensity endurance exercise — running, specifically — is one of the most reliable ways to trigger their release. This isn't fringe science or wellness marketing. It's a systematic review published in The Neuroscientist, covering 21 human clinical trials and 571 participants.

The implications run in two directions simultaneously. For the cannabis consumer, it tells you something important about what the plant is actually binding to — and why it works the way it does. For the grower, it reframes what you are cultivating. You are not producing a foreign substance that overrides the brain. You are producing plant-based versions of molecules the brain already knows, already produces, and already uses to regulate mood, pain, anxiety, and motivation.

First, the Endorphin Myth

Before we get into what the evidence actually shows, it's worth clearing the ground of what it doesn't show — because most people have been told the wrong story for decades.

The runner's high was first attributed to endorphins in the 1980s. The idea was straightforward: intense exercise releases endorphins, endorphins bind to opioid receptors, opioid receptors produce euphoria. It was widely reported, widely believed, and is still repeated today.

The problem is that endorphins are hydrophilic molecules — water-soluble. The blood-brain barrier is largely impermeable to water-soluble molecules. Peripheral endorphins physically cannot cross into the brain in meaningful quantities. The machinery needed to produce the runner's high is inside the brain. The endorphins produced in the body largely cannot reach it.

The evidence backed this up directly. When researchers blocked opioid receptors entirely using naltrexone — preventing anything from binding to those receptors — the runner's high happened anyway. Euphoria was still present. Anxiety was still reduced. The opioid system wasn't the mechanism. So what was?

The Endocannabinoid System — Your Body's Built-In Cannabis

In the early 1990s, researchers made two discoveries that changed the picture completely. In 1992, a molecule was identified in the brain that bound to the same receptors as THC. It was named anandamide — from the Sanskrit word for bliss. In 1995, a second molecule was discovered: 2-arachidonoyl glycerol, known as 2-AG.

Both are endocannabinoids — cannabinoid-like molecules produced naturally inside the body. Both are lipophilic, meaning fat-soluble. And critically, fat-soluble molecules can cross the blood-brain barrier with ease. Unlike endorphins, endocannabinoids produced in the body can actually reach the brain.

The endocannabinoid system they activate regulates synaptic transmission, mood, reward, anxiety, appetite, memory, neuroprotection, and neuroinflammation. It also plays important roles in neural development. When a cannabis grower talks about what THC does in the brain, they are talking about what the brain's own endocannabinoid system does naturally. THC is a plant-based key to a lock the body built for itself. Anandamide is the body's own key to that same lock.

What the Review Found — 21 Studies, 571 People

The systematic review published in The Neuroscientist screened 278 records and included 21 human clinical trials meeting strict criteria: aerobic exercise, minimum 20 minutes, endocannabinoid blood levels measured before and after, published in peer-reviewed journals. The 571 participants included healthy adults, athletes, people with PTSD, major depression, chronic pain, and substance use disorder.

For a field studying a molecule that degrades quickly and is difficult to measure, an 82% replication rate across independent research groups, different participant populations, and different countries is notable.

Intensity Is Everything — The 70 to 85% Window

One of the most practically useful findings in the review is that endocannabinoid release is not simply triggered by moving your body. It is triggered by moving your body at the right intensity.

A pivotal study tested the same participants on four separate days at four different intensities: walking at under 50% of maximum heart rate, and running at roughly 70%, 80%, and 90% of maximum heart rate. The result was clean: only the two middle intensities — approximately 70% and 80% of maximum heart rate — produced a significant increase in anandamide. Walking produced nothing. High-intensity running at 90% produced nothing.

What the Endocannabinoids Are Actually Doing

The runner's high has four classically described components: euphoria, reduced anxiety, reduced pain sensitivity, and sedation. Here is what the evidence shows for each in relation to endocannabinoids.

The Long-Term Paradox

Here is the finding that surprised the researchers most — and has the most significant implications for anyone thinking about regular exercise and the endocannabinoid system.

After acute exercise, endocannabinoids go up. But after long-term regular exercise programs lasting 12 weeks or more, all four studies that measured endocannabinoid levels found they went down. Not just back to baseline. Measurably below it.

The mechanism proposed is an upregulation of FAAH — fatty acid amide hydrolase — an enzyme that breaks down anandamide. In physically active people, FAAH activity in lymphocytes was found to be higher than in sedentary controls. The body, it appears, compensates for repeated endocannabinoid elevation by becoming more efficient at clearing it. The same homeostatic intelligence that governs tolerance to cannabis in regular users appears to operate in regular exercisers — not through receptor downregulation but through accelerated degradation of the molecule itself.

What this means practically is not yet clear. It may be neutral — the body adapting its baseline without losing the capacity for acute elevation during exercise. Or it may have implications for mood regulation in long-term athletes. The review flags this as a priority for future research.

The Stress Connection

The review identifies a relationship between the endocannabinoid system and the stress response that goes beyond exercise-induced euphoria.

Cortisol — the primary stress hormone — and anandamide levels were found to correlate positively. When exercise drove cortisol up, anandamide went up with it. In another study, a social stress test also increased anandamide. The researchers frame this through allostasis — the body's system for maintaining stability through change. Exercise is itself a stressor. The endocannabinoid release it triggers may be part of the body's mechanism for modulating how that stress is experienced, buffering the physiological stress signal with a neurobiological one that promotes calm and positive affect.

A study of cosmonauts during spaceflight adds a striking data point. In cosmonauts experiencing low stress, endocannabinoids were elevated. In those experiencing high stress and motion sickness, endocannabinoid elevation was absent and cortisol surged. The endocannabinoid system appears to function, at least in part, as a stress buffer — one that can be depleted by excessive stress rather than activated by it.

This is directly relevant to understanding what cannabis does therapeutically. When patients report using cannabis for anxiety, stress, or mood regulation, they are not introducing a foreign chemical that overrides normal function. They are supplementing a system that exists specifically to perform those regulatory functions — one that can be overwhelmed, depleted, or dysregulated by the conditions of modern life.

What This Means for Growers and Consumers

The relevance of this research to cannabis cultivation runs deeper than it first appears.

For anyone who grows and also uses cannabis, understanding that THC and anandamide bind to the same receptor — that the plant molecule is essentially mimicking a molecule your body already produces — reframes the experience of using cannabis in a meaningful way. It is not an alien substance producing an artificial state. It is a plant-derived key fitting a lock your brain evolved for its own purposes.

For medical growers and producers, the endocannabinoid research strengthens the biological rationale for cannabis as medicine in ways that go beyond anecdote. The anxiety reduction, mood elevation, and pain modulation that cannabis produces are all functions of the endocannabinoid system — documented in drug-free exercise studies, across hundreds of participants, in peer-reviewed journals.

And for the series of conversations we have been having here on The Grower's Connect — about what the plant is at a cellular level, what its flowers are under a microscope, what happens in the brain over a lifetime of use — this piece adds something important. The plant and the person share a receptor. The endocannabinoid system is the bridge between them. And running, it turns out, is one of the oldest ways the body has of activating that bridge on its own.